282 related articles for article (PubMed ID: 17605895)
1. Effects of folic acid and vitamin B complex on serum C-reactive protein and albumin levels in stable hemodialysis patients.
Chang TY; Chou KJ; Tseng CF; Chung HM; Fang HC; Hung YM; Wu MJ; Tzeng HM; Lind CC; Lu KC
Curr Med Res Opin; 2007 Aug; 23(8):1879-86. PubMed ID: 17605895
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
3. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
5. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
6. Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly.
Lewerin C; Ljungman S; Nilsson-Ehle H
J Intern Med; 2007 Jan; 261(1):65-73. PubMed ID: 17222169
[TBL] [Abstract][Full Text] [Related]
7. [Nutritional status, comorbidity, and inflammation in hemodialysis].
Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
[TBL] [Abstract][Full Text] [Related]
8. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia.
Undas A; Stepień E; Glowacki R; Tisończyk J; Tracz W; Jakubowski H
Thromb Haemost; 2006 Sep; 96(3):342-7. PubMed ID: 16953277
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
Bekpinar S; Unlüçerçi Y; Genç S; Türkmen A
Adv Perit Dial; 2005; 21():80-4. PubMed ID: 16686291
[TBL] [Abstract][Full Text] [Related]
10. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging.
Mizrahi EH; Jacobsen DW; Debanne SM; Traore F; Lerner AJ; Friedland RP; Petot GJ
J Nutr Health Aging; 2003; 7(3):160-5. PubMed ID: 12766793
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
Righetti M; Serbelloni P; Milani S; Ferrario G
Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum nickel and homocysteine concentration in hemodialysis patients.
Katko M; Kiss I; Karpati I; Kadar A; Matyus J; Csongradi E; Posta J; Paragh G; Balla J; Kovacs B; Varga Z
Biol Trace Elem Res; 2008 Sep; 124(3):195-205. PubMed ID: 18465090
[TBL] [Abstract][Full Text] [Related]
14. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects.
Araki R; Maruyama C; Igarashi S; Yoshida M; Maruyama T; Satoh T; Yoshida M; Umegaki K
Eur J Clin Nutr; 2006 May; 60(5):573-9. PubMed ID: 16391577
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
[TBL] [Abstract][Full Text] [Related]
17. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
Akgul A; Bilgic A; Sezer S; Arat Z; Ozdemir FN; Haberal M
J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
[TBL] [Abstract][Full Text] [Related]
18. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
Movilli E; Viola BF; Camerini C; Mazzola G; Cancarini GC
J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
[TBL] [Abstract][Full Text] [Related]
19. B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke.
Ullegaddi R; Powers HJ; Gariballa SE
Clin Sci (Lond); 2004 Nov; 107(5):477-84. PubMed ID: 15279619
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
